ORBIMED ADVISORS LLC - 30 Sep 2025 SCHEDULE 13G Report for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED CAPITAL LLC
Security: Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: VTGN
Shares outstanding: 30,705,993 shares
Disclosed Ownership: 1,639,700 shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 18:04:51 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	4.6%	1,420,300	0	1,420,300	/s/ Carl L. Gordon	Carl L. Gordon/Member
ORBIMED CAPITAL LLC	5.3%	1,639,700	1,639,700	0	/s/ Carl L. Gordon	Carl L. Gordon/Member